vs

Side-by-side financial comparison of ICON PLC (ICLR) and PACS Group, Inc. (PACS). Click either name above to swap in a different company.

ICON PLC is the larger business by last-quarter revenue ($2.0B vs $1.4B, roughly 1.5× PACS Group, Inc.). PACS Group, Inc. runs the higher net margin — 4.4% vs 0.1%, a 4.3% gap on every dollar of revenue. On growth, PACS Group, Inc. posted the faster year-over-year revenue change (18.4% vs 0.6%). Over the past eight quarters, PACS Group, Inc.'s revenue compounded faster (20.5% CAGR vs 0.6%).

ICON plc is an Irish headquartered multinational healthcare intelligence and clinical research organisation. As of February 2025 had approximately 41,900 employees in 55 countries.

ICLR vs PACS — Head-to-Head

Bigger by revenue
ICLR
ICLR
1.5× larger
ICLR
$2.0B
$1.4B
PACS
Growing faster (revenue YoY)
PACS
PACS
+17.8% gap
PACS
18.4%
0.6%
ICLR
Higher net margin
PACS
PACS
4.3% more per $
PACS
4.4%
0.1%
ICLR
Faster 2-yr revenue CAGR
PACS
PACS
Annualised
PACS
20.5%
0.6%
ICLR

Income Statement — Q3 FY2025 vs Q4 FY2025

Metric
ICLR
ICLR
PACS
PACS
Revenue
$2.0B
$1.4B
Net Profit
$2.4M
$59.7M
Gross Margin
Operating Margin
4.2%
7.0%
Net Margin
0.1%
4.4%
Revenue YoY
0.6%
18.4%
Net Profit YoY
-98.8%
3022.5%
EPS (diluted)
$0.03
$0.42

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ICLR
ICLR
PACS
PACS
Q4 25
$1.4B
Q3 25
$2.0B
$1.3B
Q2 25
$2.0B
$1.3B
Q1 25
$2.0B
$1.3B
Q4 24
$1.1B
Q3 24
$2.0B
$1.0B
Q2 24
$2.1B
$981.4M
Q1 24
$2.1B
$934.3M
Net Profit
ICLR
ICLR
PACS
PACS
Q4 25
$59.7M
Q3 25
$2.4M
$52.4M
Q2 25
$183.0M
$51.0M
Q1 25
$154.2M
$28.5M
Q4 24
$1.9M
Q3 24
$197.1M
$15.6M
Q2 24
$146.9M
$-10.9M
Q1 24
$187.4M
$49.1M
Gross Margin
ICLR
ICLR
PACS
PACS
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
17.1%
Q2 24
22.3%
Q1 24
21.2%
Operating Margin
ICLR
ICLR
PACS
PACS
Q4 25
7.0%
Q3 25
4.2%
6.4%
Q2 25
10.4%
6.2%
Q1 25
11.0%
3.8%
Q4 24
1.7%
Q3 24
14.1%
2.2%
Q2 24
10.8%
0.1%
Q1 24
13.7%
8.6%
Net Margin
ICLR
ICLR
PACS
PACS
Q4 25
4.4%
Q3 25
0.1%
3.9%
Q2 25
9.1%
3.9%
Q1 25
7.7%
2.2%
Q4 24
0.2%
Q3 24
9.7%
1.5%
Q2 24
6.9%
-1.1%
Q1 24
9.0%
5.3%
EPS (diluted)
ICLR
ICLR
PACS
PACS
Q4 25
$0.42
Q3 25
$0.03
$0.32
Q2 25
$2.30
$0.31
Q1 25
$1.90
$0.17
Q4 24
$-0.03
Q3 24
$2.36
$0.10
Q2 24
$1.76
$-0.07
Q1 24
$2.25
$0.38

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ICLR
ICLR
PACS
PACS
Cash + ST InvestmentsLiquidity on hand
$468.9M
$197.0M
Total DebtLower is stronger
$353.2M
Stockholders' EquityBook value
$9.3B
$946.8M
Total Assets
$16.5B
$5.6B
Debt / EquityLower = less leverage
0.37×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ICLR
ICLR
PACS
PACS
Q4 25
$197.0M
Q3 25
$468.9M
$355.7M
Q2 25
$390.4M
$294.2M
Q1 25
$526.7M
$287.5M
Q4 24
$157.7M
Q3 24
$695.5M
$49.5M
Q2 24
$506.6M
$73.4M
Q1 24
$396.1M
$81.2M
Total Debt
ICLR
ICLR
PACS
PACS
Q4 25
$353.2M
Q3 25
Q2 25
Q1 25
Q4 24
$411.9M
Q3 24
Q2 24
Q1 24
Stockholders' Equity
ICLR
ICLR
PACS
PACS
Q4 25
$946.8M
Q3 25
$9.3B
$871.3M
Q2 25
$9.6B
$806.8M
Q1 25
$9.5B
$750.2M
Q4 24
$709.6M
Q3 24
$9.8B
$660.0M
Q2 24
$9.6B
$572.1M
Q1 24
$9.4B
$128.0M
Total Assets
ICLR
ICLR
PACS
PACS
Q4 25
$5.6B
Q3 25
$16.5B
$5.6B
Q2 25
$16.6B
$5.5B
Q1 25
$16.7B
$5.5B
Q4 24
$5.2B
Q3 24
$17.2B
$4.5B
Q2 24
$17.0B
$3.9B
Q1 24
$17.0B
$3.9B
Debt / Equity
ICLR
ICLR
PACS
PACS
Q4 25
0.37×
Q3 25
Q2 25
Q1 25
Q4 24
0.58×
Q3 24
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ICLR
ICLR
PACS
PACS
Operating Cash FlowLast quarter
$387.6M
$-3.4M
Free Cash FlowOCF − Capex
$333.9M
FCF MarginFCF / Revenue
16.3%
Capex IntensityCapex / Revenue
2.6%
Cash ConversionOCF / Net Profit
164.59×
-0.06×
TTM Free Cash FlowTrailing 4 quarters
$1.0B

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ICLR
ICLR
PACS
PACS
Q4 25
$-3.4M
Q3 25
$387.6M
$204.8M
Q2 25
$146.2M
$52.6M
Q1 25
$268.2M
$150.2M
Q4 24
$64.6M
Q3 24
$402.7M
$209.2M
Q2 24
$218.6M
$34.8M
Q1 24
$327.1M
$58.8M
Free Cash Flow
ICLR
ICLR
PACS
PACS
Q4 25
Q3 25
$333.9M
Q2 25
$113.9M
Q1 25
$239.3M
Q4 24
Q3 24
$359.3M
Q2 24
$182.3M
Q1 24
$299.9M
FCF Margin
ICLR
ICLR
PACS
PACS
Q4 25
Q3 25
16.3%
Q2 25
5.6%
Q1 25
12.0%
Q4 24
Q3 24
17.7%
Q2 24
8.6%
Q1 24
14.3%
Capex Intensity
ICLR
ICLR
PACS
PACS
Q4 25
Q3 25
2.6%
Q2 25
1.6%
Q1 25
1.4%
Q4 24
Q3 24
2.1%
Q2 24
1.7%
Q1 24
1.3%
Cash Conversion
ICLR
ICLR
PACS
PACS
Q4 25
-0.06×
Q3 25
164.59×
3.91×
Q2 25
0.80×
1.03×
Q1 25
1.74×
5.28×
Q4 24
33.78×
Q3 24
2.04×
13.39×
Q2 24
1.49×
Q1 24
1.74×
1.20×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ICLR
ICLR

Other Customers$681.3M33%
Clients1125$549.4M27%
Clients15$503.3M25%
Clients610$308.8M15%

PACS
PACS

Segment breakdown not available.

Related Comparisons